FSTEX | VENAX | FSTEX / VENAX | |
Total Expense Ratio | 1.27 | 0.09 | 1,411% |
Annual Report Gross Expense Ratio | 1.27 | 0.09 | 1,411% |
Fund Existence | 41 years | 21 years | - |
Gain YTD | 7.987 | 2.198 | 363% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 438M | 8.11B | 5% |
Annual Yield % from dividends | 4.06 | 3.43 | 118% |
Returns for 1 year | 8.62 | 0.24 | 3,625% |
Returns for 3 years | 19.68 | 6.83 | 288% |
Returns for 5 years | 174.59 | 134.79 | 130% |
Returns for 10 years | 9.58 | 14.14 | 68% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HSGFX | 6.41 | 0.02 | +0.31% |
Hussman Strategic Market Cycle Fund | |||
EMGCX | 23.58 | -0.27 | -1.13% |
Allspring Emerging Markets Equity C | |||
GSMSX | 34.41 | -0.47 | -1.35% |
Goldman Sachs Mid Cap Value Svc | |||
RSLAX | 58.55 | -0.91 | -1.52% |
American Funds SMALLCAP World R1 | |||
NWHDX | 14.32 | -0.27 | -1.85% |
Nationwide Bailard Cogntv Val A |